3rd Quarter - Report
DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.) for DEFINIUM THERAPEUTICS (FKA MIND MEDICINE (MINDMED) INC.)
Income
—
Expenses
$130,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Lack of innovation in mental health. Need for more efficient communication/collaboration between FDA/DEA and need for VA to operationalize itself for when new therapies are approved by the FDA and rescheduled by the DEA.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE GARNER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.